There is potential upside of 1.6% for shares of Johnson&Johnson based on a current price of $132.10 and an average consensus analyst price target of $134.24. The stock should find initial support at its 50-day moving average (MA) of …
ZURICH (Reuters) - Shares in Idorsia (IDIA.S), the drug pipeline firm spun off from biotech group Actelion (ATLN.S) after Johnson & Johnson’s (JNJ.N ... One trader said Idorsia’s stock had been trading over the counter this week at around …
Johnson & Johnson’s bid for Synthes, a Swiss-American medical equipment manufacturer, makes a lot of strategic sense. The $21.3 billion deal will give Johnson & Johnson a leading position in the main orthopedic device markets. …
Johnson & Johnson's stock shed 1% in premarket trade Tuesday, after the drug and consumer products giant reported first-quarter profit that beat expectations but sales that missed. Net earnings came to $4.42 billion, or $1.61 a share, …
Arena Pharmaceuticals has posted positive data from a phase 2 trial of its pulmonary arterial hypertension (PAH) …
Unexpectedly strong earnings reports from heavyweights like Mattel and Johnson & Johnson streamed in on Tuesday, …
Humana closed Friday at $146.75. Johnson & Johnson (NYSE: JNJ) is the top market cap pharmaceutical stock in the health care sector and likely will raise the dividend for shareholders this year for the 52nd consecutive year. With …
Ben Bernanke, clearly no Keynesian, recently delivered a speech entitled "Economic Prospects for the Long Run." What, then, would he make of the extremely short-term stock gyrations caused by his every muttering? The Dow (^DJI), up …
Johnson & Johnson stock fell this morning after the disclosure of the deaths, and trading was halted briefly on the New York Stock Exchange. It closed at 48, off 2 1/4. The Zomax problem comes five months after Tylenol capsules, a …
(RTTNews) - Shares of Medivir AB (MVRBF.PK) were losing around 8 percent in the morning trading in Stockholm after the research-based pharmaceutical company with a focus on oncology announced that Janssen Research & Development …